Mitochondrial & longevity peptides
Mitochondria-derived and longevity-associated research peptides. Among the most hype-prone and least clinically validated groups.
How this class works
Proposed roles include mitochondrial function and stress-response signalling. Evidence is predominantly preclinical or mechanistic; longevity claims are generally unproven in humans.
SS 31 grades highest (C-tier) on current published evidence. This reflects evidence maturity — not a recommendation to use anything.
Compounds in this class
Head-to-head: SS 31 vs Mots C
FAQ
Which mitochondrial & longevity peptides has the strongest evidence?
SS 31 currently grades highest in this class (C-tier) on published evidence — which reflects evidence maturity, not a recommendation.
Are any mitochondrial & longevity peptides FDA-approved?
No members of this class are FDA-approved; they are investigational or research-only.
How do compounds in this class differ?
Proposed roles include mitochondrial function and stress-response signalling. Evidence is predominantly preclinical or mechanistic; longevity claims are generally unproven in humans. Within the class, members differ widely in evidence maturity, approval status, and safety — the tiers and evidence stages above show how.
Research reference only. Not medical advice. Compounds in a class can differ greatly in evidence, approval status, and safety.